Bonsu, Kwadwo Osei
Young, Stephanie W.
Lee, Tiffany
Nguyen, Hai V.
Chitsike, Rufaro S.
Funding for this research was provided by:
Sanofi, Canada
Bayer Canada
Pfizer Canada
Article History
Received: 14 July 2022
Accepted: 5 November 2022
First Online: 18 November 2022
Declarations
:
: The survey and protocol were reviewed by the Health Research Ethics Board of NL, and it was determined that the project was a quality assurance/quality improvement project, and as such did not require ethics review.
: Participants were free to answer to the survey, and their responses served as consent to take part in the study.
: Not applicable. Aggregated data is reported in the manuscript and individual patient data or image would not be published.
: Survey authors granted permission to utilize the 12-item Adherence to Refills and Medications Scale (ARMS).
: Kwadwo Osei Bonsu received a postdoctoral fellow salary from an unrestricted grant provided by Sanofi Canada. For research and clinical activities outside the work presented here, Rufaro Chitsike and Stephanie Young have received unrestricted grants from Sanofi Canada and Bayer Canada. Rufaro Chitsike received speaking honoraria from Pfizer Canada. No other competing interests to declare.